Mkts

vTv Therapeutics Inc.

NASDAQ: VTVT
$22.11-1.92 (-7.99%)
As of Nov 5, 9:30 AM ET

Key statistics

Day range
21.7323.20
52-week range
21.7344.00
Today
Open23.20
Previous close22.11
Volume191
Valuation
Market cap106.59M
P/E ratio—
EPS (TTM)-1.06
Income & risk
Dividend / yield—
Beta0.25
Avg volume20.9K
Discussion

VTVT News

Stories mentioning VTVT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue36,8390.000.000.000.0017.000.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development8,9783,9087,0204,1032,8302,2343,2243,439
Sales General & Admin
Total Operating Expenses13,5767,88510,6997,7216,5034,9096,5067,155
Operating Income (Loss)23,263(7,885)(10,699)(7,721)(6,503)(4,892)(6,506)(7,155)
Interest Income838.00865.00399.00275.00331.00429.00504.00553.00
Interest Expense
Other Expense
Pretax Income24,134(7,138)(10,345)(7,380)(6,217)(4,437)(5,840)(6,409)
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)24,134(7,138)(8,698)(6,046)(5,092)(3,634)(4,783)(5,180)
Earnings Per Share (Basic)
Earnings Per Share (Diluted)
Weighted Average Shares Outstanding (Basic)
Weighted Average Shares Outstanding (Diluted)

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VTVT

vTv Therapeutics Inc. (NASDAQ: VTVT) is a stock listed on the Nasdaq Stock Market under the ticker symbol VTVT. It last traded at $22.11 (Nov 5, 2026, 9:30 AM ET), down 8.0% on the day. That gives vTv Therapeutics a market capitalisation of $106.6M.

Over the past 52 weeks VTVT has traded between $21.73 and $44.00.

Revenue for the quarter ended Mar 31, 2026 was $36.8M; net income $24.1M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$36.8M$24.1M65.5%
Dec 31, 2025$0-$7.1M—
Sep 30, 2025$0-$8.7M—
Jun 30, 2025$0-$6.0M—

From vTv Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…